A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV. Strengthening and redirecting the immune system’s anti-HIV response are the primary goals of the five-year study. “The first… Read More
The Triangle Immunology and Virology Interest Group is hosting a meeting: “Resistance, Immunity and Vaccines: Lessons from our Feathered Friends” Matt Koci Prestage Department of Poultry Science, North Carolina State University Wednesday, February 4, 2015 at 6:00 pm North Carolina Biotechnology Center Pizza and salad will be served following the talk.
World AIDS Day Clinical Trials Twitter Chat and an ‘HIV Clinical Trials: A Year in Review’ Webinar Featuring presentations by Jim Maynard of the HIV Vaccine Trials Network, Jonathan Lucas of the HIV Prevention Trials Network and Clare Collins of the Microbicide Trials Network WAD Clinical Trials Twitter Chat Date: Wednesday November 19, 2014 Time:… Read More
This talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series. “Humoral Immunity Benchmarks for Advancing HIV-1 Vaccine Candidates” Georgia Tomaras, Ph.D. Duke Human Vaccine Institute November 14, 2014 8:30 – 9:30 a.m. 1131 Bioinformatics UNC Campus Dr. Georgia Tomaras is a tenured Associate Professor of Surgery, Immunology, and Molecular Genetics and… Read More